168 related articles for article (PubMed ID: 33235154)
21. Upfront chemotherapy followed by response adaptive radiotherapy for intracranial germinoma: Prospective multicenter cohort study.
Lee DS; Lim DH; Kim IH; Kim JY; Han JW; Yoo KH; Park KD; Park HJ; Chung NG; Suh CO; Kim DS
Radiother Oncol; 2019 Sep; 138():180-186. PubMed ID: 31319280
[TBL] [Abstract][Full Text] [Related]
22. Treatment outcomes of intracranial germinoma: a retrospective analysis of 170 patients from a single institution.
Lian X; Hou X; Yan J; Sun S; Miao Z; Liu Z; Wang W; Shen J; Shen J; Hu K; Zhang F
J Cancer Res Clin Oncol; 2019 Mar; 145(3):709-715. PubMed ID: 30209611
[TBL] [Abstract][Full Text] [Related]
23. Phase II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors.
Motzer RJ; Mazumdar M; Gulati SC; Bajorin DF; Lyn P; Vlamis V; Bosl GJ
J Natl Cancer Inst; 1993 Nov; 85(22):1828-35. PubMed ID: 7693955
[TBL] [Abstract][Full Text] [Related]
24. [Treatment outcome of primary central nervous system germ cell tumors after combined therapy: a report of 23 cases].
Yang QY; Sun XF; Huang HQ; Zhen ZJ; Xia Y; Cai QQ; Ling JY
Ai Zheng; 2008 Apr; 27(4):438-41. PubMed ID: 18423134
[TBL] [Abstract][Full Text] [Related]
25. Secreting germ cell tumors of the central nervous system (CNS). First results of the cooperative German/Italian pilot study (CNS sGCT).
Calaminus G; Andreussi L; Garré ML; Kortmann RD; Schober R; Göbel U
Klin Padiatr; 1997; 209(4):222-7. PubMed ID: 9293454
[TBL] [Abstract][Full Text] [Related]
26. Cisplatin-based chemotherapy followed by focal, reduced-dose irradiation for pediatric primary central nervous system germinomas.
Douglas JG; Rockhill JK; Olson JM; Ellenbogen RG; Geyer JR
J Pediatr Hematol Oncol; 2006 Jan; 28(1):36-9. PubMed ID: 16394891
[TBL] [Abstract][Full Text] [Related]
27. Phase II Trial of Response-Based Radiation Therapy for Patients With Localized CNS Nongerminomatous Germ Cell Tumors: A Children's Oncology Group Study.
Fangusaro J; Wu S; MacDonald S; Murphy E; Shaw D; Bartels U; Khatua S; Souweidane M; Lu HM; Morris D; Panigrahy A; Onar-Thomas A; Fouladi M; Gajjar A; Dhall G
J Clin Oncol; 2019 Dec; 37(34):3283-3290. PubMed ID: 31545689
[TBL] [Abstract][Full Text] [Related]
28. Long term outcomes in patients with intracranial germinomas: a single institution experience of irradiation with or without chemotherapy.
Kawabata Y; Takahashi JA; Arakawa Y; Shirahata M; Hashimoto N
J Neurooncol; 2008 Jun; 88(2):161-7. PubMed ID: 18286232
[TBL] [Abstract][Full Text] [Related]
29. Intensive cisplatin and cyclophosphamide-based chemotherapy without radiotherapy for intracranial germinomas: failure of a primary chemotherapy approach.
Kellie SJ; Boyce H; Dunkel IJ; Diez B; Rosenblum M; Brualdi L; Finlay JL
Pediatr Blood Cancer; 2004 Aug; 43(2):126-33. PubMed ID: 15236278
[TBL] [Abstract][Full Text] [Related]
30. Significance of human chorionic gonadotropin as a predictor of resistance to standard chemo-radiotherapy for pure germinoma.
Inoue A; Ohnishi T; Kohno S; Ohue S; Iwata S; Matsumoto S; Nishikawa M; Ozaki S; Nakamura Y; Mizuno Y; Kitazawa R; Kunieda T
Neurosurg Rev; 2018 Apr; 41(2):557-565. PubMed ID: 28819802
[TBL] [Abstract][Full Text] [Related]
31. Outcome of patients with intracranial non-germinomatous germ cell tumors-lessons from the SIOP-CNS-GCT-96 trial.
Calaminus G; Frappaz D; Kortmann RD; Krefeld B; Saran F; Pietsch T; Vasiljevic A; Garre ML; Ricardi U; Mann JR; Göbel U; Alapetite C; Murray MJ; Nicholson JC
Neuro Oncol; 2017 Nov; 19(12):1661-1672. PubMed ID: 29048505
[TBL] [Abstract][Full Text] [Related]
32. Determining an Optimal Cutoff of Serum β-Human Chorionic Gonadotropin for Assisting the Diagnosis of Intracranial Germinomas.
Zhang H; Zhang P; Fan J; Qiu B; Pan J; Zhang X; Fang L; Qi S
PLoS One; 2016; 11(1):e0147023. PubMed ID: 26771195
[TBL] [Abstract][Full Text] [Related]
33. SIOP CNS GCT 96: final report of outcome of a prospective, multinational nonrandomized trial for children and adults with intracranial germinoma, comparing craniospinal irradiation alone with chemotherapy followed by focal primary site irradiation for patients with localized disease.
Calaminus G; Kortmann R; Worch J; Nicholson JC; Alapetite C; Garrè ML; Patte C; Ricardi U; Saran F; Frappaz D
Neuro Oncol; 2013 Jun; 15(6):788-96. PubMed ID: 23460321
[TBL] [Abstract][Full Text] [Related]
34. Impact of margin for target volume in low-dose involved field radiotherapy after induction chemotherapy for intracranial germinoma.
Shirato H; Aoyama H; Ikeda J; Fujieda K; Kato N; Ishi N; Miyasaka K; Iwasaki Y; Sawamura Y
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):214-7. PubMed ID: 15337558
[TBL] [Abstract][Full Text] [Related]
35. Improved outcome of central nervous system germ cell tumors: implications for the role of risk-adapted intensive chemotherapy.
Yoo KH; Lee SH; Lee J; Sung KW; Jung HL; Koo HH; Lim DH; Kim JH; Shin HJ
J Korean Med Sci; 2010 Mar; 25(3):458-65. PubMed ID: 20191048
[TBL] [Abstract][Full Text] [Related]
36. The clinical characteristics and treatment outcome of 57 children and adolescents with primary central nervous system germ cell tumors.
Sun XF; Zhang F; Zhen ZJ; Yang QY; Xia YF; Wu SX; Zhu J; Lu SY; Wang J; Sun FF; Cai RQ; Chen Y; Li PF
Chin J Cancer; 2014 Aug; 33(8):395-401. PubMed ID: 25011460
[TBL] [Abstract][Full Text] [Related]
37. Primary central nervous system germ cell tumors.
Kaur H; Singh D; Peereboom DM
Curr Treat Options Oncol; 2003 Dec; 4(6):491-8. PubMed ID: 14585229
[TBL] [Abstract][Full Text] [Related]
38. Human chorionic gonadotropin detection in cerebrospinal fluid of patients with a germinoma and its prognostic significance: assessment by using a highly sensitive enzyme immunoassay.
Fukuoka K; Yanagisawa T; Suzuki T; Shirahata M; Adachi JI; Mishima K; Fujimaki T; Katakami H; Matsutani M; Nishikawa R
J Neurosurg Pediatr; 2016 Nov; 18(5):573-577. PubMed ID: 27391806
[TBL] [Abstract][Full Text] [Related]
39. Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours.
Fizazi K; Prow DM; Do KA; Wang X; Finn L; Kim J; Daliani D; Papandreou CN; Tu SM; Millikan RE; Pagliaro LC; Logothetis CJ; Amato RJ
Br J Cancer; 2002 May; 86(10):1555-60. PubMed ID: 12085204
[TBL] [Abstract][Full Text] [Related]
40. Time to dismiss boost? Outcomes of children with localized and metastatic germinoma.
Foo JC; Yaman Bajin I; Marushchak O; McKeown T; Bouffet E; Tsang DS; Laperriere N; Dirks P; Drake J; Ertl-Wagner B; Bartels U
J Neurooncol; 2023 Apr; 162(2):443-448. PubMed ID: 37039951
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
